Sunrest Lifescience Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	41.16	20.05	2.26	20.43	7.77
Depreciation & Amortization	11.92	0.95	0.97	1.3	0.6
Loss (Gain) From Sale of Assets	-21.46	0	-	-	-0.22
Other Operating Activities	58.85	4.41	-2.51	3.8	2.04
Change in Accounts Receivable	39.02	-41.15	-41.41	-15.11	-19.45
Change in Inventory	-74.36	-17.26	-11.1	-16.46	-7.74
Change in Accounts Payable	-19.14	91.77	-48.23	6.86	15.22
Change in Other Net Operating Assets	-36.5	-29.57	-47.96	10.73	-2.71
Operating Cash Flow	-0.5	29.21	-147.98	11.55	-4.49
Capital Expenditures	-75.18	-13.72	-0.07	-0.14	-4.67
Sale of Property, Plant & Equipment	48.09	2.1	-	-	1.1
Investment in Securities	-2.04	0.17	-	-0.17	-
Investing Cash Flow	-29.14	-11.45	-0.07	-0.31	-3.56
Long-Term Debt Issued	54.08	0.38	40.17	-	9.23
Long-Term Debt Repaid	-	-0.61	-	-10.95	-
Net Debt Issued (Repaid)	54.08	-0.23	40.17	-10.95	9.23
Issuance of Common Stock	-	-	108.46	-	-
Other Financing Activities	-14.18	-3.04	-2.18	-0.59	-0.11
Financing Cash Flow	39.9	-3.27	146.44	-11.54	9.12
Miscellaneous Cash Flow Adjustments	-	-	-0	-	-
Net Cash Flow	10.26	14.49	-1.6	-0.3	1.07
Free Cash Flow	-75.68	15.49	-148.05	11.41	-9.15
Free Cash Flow Margin	-10.69%	4.64%	-50.21%	4.63%	-3.40%
Free Cash Flow Per Share	-17.64	3.61	-44.55	3.80	-3.05
Cash Interest Paid	14.18	3.05	2.18	0.59	0.11
Cash Income Tax Paid	15.2	4.81	8.36	3.8	0.8
Levered Free Cash Flow	-85.31	-71.2	-147.76	7.91	-10.42
Unlevered Free Cash Flow	-76.45	-69.39	-147.35	8.28	-10.28
Change in Working Capital	-90.98	3.79	-148.7	-13.98	-14.67